aluates Reports

$ 0.0

Automative

Global Irritable Bowel Syndrome with Constipation Drugs Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-6Y8831

Global Irritable Bowel Syndrome with Constipation Drugs Market Insights and Forecast to 2028

BUY CHAPTERS

Global Irritable Bowel Syndrome with Constipation Drugs Market Research Report 2025

Code: QYRE-Auto-6Y8831

Report

September 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Nestle S A

Abbot Laboratories

Synergy Pharmaceuticals

Sucampo Pharmaceuticals

Novartis

Astellas Pharmaceuticals

Mallinckrodt plc

Bausch Health Companies

Ardelyx Inc

Ironwood Pharmaceuticals

Takeda Pharmaceutical

Irritable Bowel Syndrome with Constipation Drugs Market Size

The global market for Irritable Bowel Syndrome with Constipation Drugs was valued at US$ 1921 million in the year 2024 and is projected to reach a revised size of US$ 4412 million by 2031, growing at a CAGR of 12.8% during the forecast period.

Irritable Bowel Syndrome with Constipation Drugs Market

The symptoms of IBS-C include abdominal pain and discomfort, along with changes in bowel function. Bloating and/or gas also may happen. Changes in bowel function may include straining, infrequent stools, hard or lumpy stools, and/or a feeling that the bowel does not empty completely.

North American market for Irritable Bowel Syndrome with Constipation Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Irritable Bowel Syndrome with Constipation Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Irritable Bowel Syndrome with Constipation Drugs in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Irritable Bowel Syndrome with Constipation Drugs include Nestle, Abbot Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Novartis, Astellas Pharmaceuticals, Mallinckrodt, Bausch Health Companies, Ardelyx, Ironwood Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome with Constipation Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome with Constipation Drugs.

The Irritable Bowel Syndrome with Constipation Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Irritable Bowel Syndrome with Constipation Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Irritable Bowel Syndrome with Constipation Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Irritable Bowel Syndrome with Constipation Drugs Market Report

Report Metric	Details
Report Name	Irritable Bowel Syndrome with Constipation Drugs Market
Accounted market size in year	US$ 1921 million
Forecasted market size in 2031	US$ 4412 million
CAGR	12.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Lubiprostone Linaclotide Stimulant Laxatives Osmotic Laxatives Others
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Nestle, Abbot Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Novartis, Astellas Pharmaceuticals, Mallinckrodt, Bausch Health Companies, Ardelyx, Ironwood Pharmaceuticals, Takeda Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Irritable Bowel Syndrome with Constipation Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Irritable Bowel Syndrome with Constipation Drugs Market growing?

Ans: The Irritable Bowel Syndrome with Constipation Drugs Market witnessing a CAGR of 12.8% during the forecast period 2025-2031.

What is the Irritable Bowel Syndrome with Constipation Drugs Market size in 2031?

Ans: The Irritable Bowel Syndrome with Constipation Drugs Market size in 2031 will be US$ 4412 million.

Who are the main players in the Irritable Bowel Syndrome with Constipation Drugs Market report?

Ans: The main players in the Irritable Bowel Syndrome with Constipation Drugs Market are Nestle, Abbot Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Novartis, Astellas Pharmaceuticals, Mallinckrodt, Bausch Health Companies, Ardelyx, Ironwood Pharmaceuticals, Takeda Pharmaceutical

What are the Application segmentation covered in the Irritable Bowel Syndrome with Constipation Drugs Market report?

Ans: The Applications covered in the Irritable Bowel Syndrome with Constipation Drugs Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Irritable Bowel Syndrome with Constipation Drugs Market report?

Ans: The Types covered in the Irritable Bowel Syndrome with Constipation Drugs Market report are Lubiprostone, Linaclotide, Stimulant Laxatives, Osmotic Laxatives, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Irritable Bowel Syndrome with Constipation Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Lubiprostone

1.2.3 Linaclotide

1.2.4 Stimulant Laxatives

1.2.5 Osmotic Laxatives

1.2.6 Others

1.3 Market by Application

1.3.1 Global Irritable Bowel Syndrome with Constipation Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Irritable Bowel Syndrome with Constipation Drugs Market Perspective (2020-2031)

2.2 Global Irritable Bowel Syndrome with Constipation Drugs Growth Trends by Region

2.2.1 Global Irritable Bowel Syndrome with Constipation Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Irritable Bowel Syndrome with Constipation Drugs Historic Market Size by Region (2020-2025)

2.2.3 Irritable Bowel Syndrome with Constipation Drugs Forecasted Market Size by Region (2026-2031)

2.3 Irritable Bowel Syndrome with Constipation Drugs Market Dynamics

2.3.1 Irritable Bowel Syndrome with Constipation Drugs Industry Trends

2.3.2 Irritable Bowel Syndrome with Constipation Drugs Market Drivers

2.3.3 Irritable Bowel Syndrome with Constipation Drugs Market Challenges

2.3.4 Irritable Bowel Syndrome with Constipation Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Irritable Bowel Syndrome with Constipation Drugs Players by Revenue

3.1.1 Global Top Irritable Bowel Syndrome with Constipation Drugs Players by Revenue (2020-2025)

3.1.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Irritable Bowel Syndrome with Constipation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Irritable Bowel Syndrome with Constipation Drugs Revenue

3.4 Global Irritable Bowel Syndrome with Constipation Drugs Market Concentration Ratio

3.4.1 Global Irritable Bowel Syndrome with Constipation Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome with Constipation Drugs Revenue in 2024

3.5 Global Key Players of Irritable Bowel Syndrome with Constipation Drugs Head office and Area Served

3.6 Global Key Players of Irritable Bowel Syndrome with Constipation Drugs, Product and Application

3.7 Global Key Players of Irritable Bowel Syndrome with Constipation Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Irritable Bowel Syndrome with Constipation Drugs Breakdown Data by Type

4.1 Global Irritable Bowel Syndrome with Constipation Drugs Historic Market Size by Type (2020-2025)

4.2 Global Irritable Bowel Syndrome with Constipation Drugs Forecasted Market Size by Type (2026-2031)

5 Irritable Bowel Syndrome with Constipation Drugs Breakdown Data by Application

5.1 Global Irritable Bowel Syndrome with Constipation Drugs Historic Market Size by Application (2020-2025)

5.2 Global Irritable Bowel Syndrome with Constipation Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Irritable Bowel Syndrome with Constipation Drugs Market Size (2020-2031)

6.2 North America Irritable Bowel Syndrome with Constipation Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2020-2025)

6.4 North America Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Irritable Bowel Syndrome with Constipation Drugs Market Size (2020-2031)

7.2 Europe Irritable Bowel Syndrome with Constipation Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2020-2025)

7.4 Europe Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Irritable Bowel Syndrome with Constipation Drugs Market Size (2020-2031)

8.2 Asia-Pacific Irritable Bowel Syndrome with Constipation Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Irritable Bowel Syndrome with Constipation Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Irritable Bowel Syndrome with Constipation Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Irritable Bowel Syndrome with Constipation Drugs Market Size (2020-2031)

9.2 Latin America Irritable Bowel Syndrome with Constipation Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2020-2025)

9.4 Latin America Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Irritable Bowel Syndrome with Constipation Drugs Market Size (2020-2031)

10.2 Middle East & Africa Irritable Bowel Syndrome with Constipation Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Nestle

11.1.1 Nestle Company Details

11.1.2 Nestle Business Overview

11.1.3 Nestle Irritable Bowel Syndrome with Constipation Drugs Introduction

11.1.4 Nestle Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

11.1.5 Nestle Recent Development

11.2 Abbot Laboratories

11.2.1 Abbot Laboratories Company Details

11.2.2 Abbot Laboratories Business Overview

11.2.3 Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Introduction

11.2.4 Abbot Laboratories Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

11.2.5 Abbot Laboratories Recent Development

11.3 Synergy Pharmaceuticals

11.3.1 Synergy Pharmaceuticals Company Details

11.3.2 Synergy Pharmaceuticals Business Overview

11.3.3 Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Introduction

11.3.4 Synergy Pharmaceuticals Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

11.3.5 Synergy Pharmaceuticals Recent Development

11.4 Sucampo Pharmaceuticals

11.4.1 Sucampo Pharmaceuticals Company Details

11.4.2 Sucampo Pharmaceuticals Business Overview

11.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Introduction

11.4.4 Sucampo Pharmaceuticals Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

11.4.5 Sucampo Pharmaceuticals Recent Development

11.5 Novartis

11.5.1 Novartis Company Details

11.5.2 Novartis Business Overview

11.5.3 Novartis Irritable Bowel Syndrome with Constipation Drugs Introduction

11.5.4 Novartis Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

11.5.5 Novartis Recent Development

11.6 Astellas Pharmaceuticals

11.6.1 Astellas Pharmaceuticals Company Details

11.6.2 Astellas Pharmaceuticals Business Overview

11.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Introduction

11.6.4 Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

11.6.5 Astellas Pharmaceuticals Recent Development

11.7 Mallinckrodt

11.7.1 Mallinckrodt Company Details

11.7.2 Mallinckrodt Business Overview

11.7.3 Mallinckrodt Irritable Bowel Syndrome with Constipation Drugs Introduction

11.7.4 Mallinckrodt Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

11.7.5 Mallinckrodt Recent Development

11.8 Bausch Health Companies

11.8.1 Bausch Health Companies Company Details

11.8.2 Bausch Health Companies Business Overview

11.8.3 Bausch Health Companies Irritable Bowel Syndrome with Constipation Drugs Introduction

11.8.4 Bausch Health Companies Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

11.8.5 Bausch Health Companies Recent Development

11.9 Ardelyx

11.9.1 Ardelyx Company Details

11.9.2 Ardelyx Business Overview

11.9.3 Ardelyx Irritable Bowel Syndrome with Constipation Drugs Introduction

11.9.4 Ardelyx Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

11.9.5 Ardelyx Recent Development

11.10 Ironwood Pharmaceuticals

11.10.1 Ironwood Pharmaceuticals Company Details

11.10.2 Ironwood Pharmaceuticals Business Overview

11.10.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Introduction

11.10.4 Ironwood Pharmaceuticals Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

11.10.5 Ironwood Pharmaceuticals Recent Development

11.11 Takeda Pharmaceutical

11.11.1 Takeda Pharmaceutical Company Details

11.11.2 Takeda Pharmaceutical Business Overview

11.11.3 Takeda Pharmaceutical Irritable Bowel Syndrome with Constipation Drugs Introduction

11.11.4 Takeda Pharmaceutical Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

11.11.5 Takeda Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Nestle S A

Abbot Laboratories

Synergy Pharmaceuticals

Sucampo Pharmaceuticals

Novartis

Astellas Pharmaceuticals

Mallinckrodt plc

Bausch Health Companies

Ardelyx Inc

Ironwood Pharmaceuticals

Takeda Pharmaceutical

List of Tables

Table 1. Global Irritable Bowel Syndrome with Constipation Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Lubiprostone

Table 3. Key Players of Linaclotide

Table 4. Key Players of Stimulant Laxatives

Table 5. Key Players of Osmotic Laxatives

Table 6. Key Players of Others

Table 7. Global Irritable Bowel Syndrome with Constipation Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Irritable Bowel Syndrome with Constipation Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Irritable Bowel Syndrome with Constipation Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Irritable Bowel Syndrome with Constipation Drugs Market Share by Region (2020-2025)

Table 11. Global Irritable Bowel Syndrome with Constipation Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Irritable Bowel Syndrome with Constipation Drugs Market Share by Region (2026-2031)

Table 13. Irritable Bowel Syndrome with Constipation Drugs Market Trends

Table 14. Irritable Bowel Syndrome with Constipation Drugs Market Drivers

Table 15. Irritable Bowel Syndrome with Constipation Drugs Market Challenges

Table 16. Irritable Bowel Syndrome with Constipation Drugs Market Restraints

Table 17. Global Irritable Bowel Syndrome with Constipation Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Irritable Bowel Syndrome with Constipation Drugs Market Share by Players (2020-2025)

Table 19. Global Top Irritable Bowel Syndrome with Constipation Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome with Constipation Drugs as of 2024)

Table 20. Ranking of Global Top Irritable Bowel Syndrome with Constipation Drugs Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Irritable Bowel Syndrome with Constipation Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Irritable Bowel Syndrome with Constipation Drugs, Headquarters and Area Served

Table 23. Global Key Players of Irritable Bowel Syndrome with Constipation Drugs, Product and Application

Table 24. Global Key Players of Irritable Bowel Syndrome with Constipation Drugs, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Irritable Bowel Syndrome with Constipation Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Type (2020-2025)

Table 28. Global Irritable Bowel Syndrome with Constipation Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Type (2026-2031)

Table 30. Global Irritable Bowel Syndrome with Constipation Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Application (2020-2025)

Table 32. Global Irritable Bowel Syndrome with Constipation Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Application (2026-2031)

Table 34. North America Irritable Bowel Syndrome with Constipation Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Irritable Bowel Syndrome with Constipation Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Irritable Bowel Syndrome with Constipation Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Irritable Bowel Syndrome with Constipation Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Irritable Bowel Syndrome with Constipation Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Irritable Bowel Syndrome with Constipation Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Irritable Bowel Syndrome with Constipation Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 49. Nestle Company Details

Table 50. Nestle Business Overview

Table 51. Nestle Irritable Bowel Syndrome with Constipation Drugs Product

Table 52. Nestle Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025) & (US$ Million)

Table 53. Nestle Recent Development

Table 54. Abbot Laboratories Company Details

Table 55. Abbot Laboratories Business Overview

Table 56. Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Product

Table 57. Abbot Laboratories Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025) & (US$ Million)

Table 58. Abbot Laboratories Recent Development

Table 59. Synergy Pharmaceuticals Company Details

Table 60. Synergy Pharmaceuticals Business Overview

Table 61. Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product

Table 62. Synergy Pharmaceuticals Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025) & (US$ Million)

Table 63. Synergy Pharmaceuticals Recent Development

Table 64. Sucampo Pharmaceuticals Company Details

Table 65. Sucampo Pharmaceuticals Business Overview

Table 66. Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product

Table 67. Sucampo Pharmaceuticals Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025) & (US$ Million)

Table 68. Sucampo Pharmaceuticals Recent Development

Table 69. Novartis Company Details

Table 70. Novartis Business Overview

Table 71. Novartis Irritable Bowel Syndrome with Constipation Drugs Product

Table 72. Novartis Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025) & (US$ Million)

Table 73. Novartis Recent Development

Table 74. Astellas Pharmaceuticals Company Details

Table 75. Astellas Pharmaceuticals Business Overview

Table 76. Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product

Table 77. Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025) & (US$ Million)

Table 78. Astellas Pharmaceuticals Recent Development

Table 79. Mallinckrodt Company Details

Table 80. Mallinckrodt Business Overview

Table 81. Mallinckrodt Irritable Bowel Syndrome with Constipation Drugs Product

Table 82. Mallinckrodt Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025) & (US$ Million)

Table 83. Mallinckrodt Recent Development

Table 84. Bausch Health Companies Company Details

Table 85. Bausch Health Companies Business Overview

Table 86. Bausch Health Companies Irritable Bowel Syndrome with Constipation Drugs Product

Table 87. Bausch Health Companies Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025) & (US$ Million)

Table 88. Bausch Health Companies Recent Development

Table 89. Ardelyx Company Details

Table 90. Ardelyx Business Overview

Table 91. Ardelyx Irritable Bowel Syndrome with Constipation Drugs Product

Table 92. Ardelyx Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025) & (US$ Million)

Table 93. Ardelyx Recent Development

Table 94. Ironwood Pharmaceuticals Company Details

Table 95. Ironwood Pharmaceuticals Business Overview

Table 96. Ironwood Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product

Table 97. Ironwood Pharmaceuticals Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025) & (US$ Million)

Table 98. Ironwood Pharmaceuticals Recent Development

Table 99. Takeda Pharmaceutical Company Details

Table 100. Takeda Pharmaceutical Business Overview

Table 101. Takeda Pharmaceutical Irritable Bowel Syndrome with Constipation Drugs Product

Table 102. Takeda Pharmaceutical Revenue in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025) & (US$ Million)

Table 103. Takeda Pharmaceutical Recent Development

Table 104. Research Programs/Design for This Report

Table 105. Key Data Information from Secondary Sources

Table 106. Key Data Information from Primary Sources

Table 107. Authors List of This Report

List of Figures

Figure 1. Irritable Bowel Syndrome with Constipation Drugs Picture

Figure 2. Global Irritable Bowel Syndrome with Constipation Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Irritable Bowel Syndrome with Constipation Drugs Market Share by Type: 2024 VS 2031

Figure 4. Lubiprostone Features

Figure 5. Linaclotide Features

Figure 6. Stimulant Laxatives Features

Figure 7. Osmotic Laxatives Features

Figure 8. Others Features

Figure 9. Global Irritable Bowel Syndrome with Constipation Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Irritable Bowel Syndrome with Constipation Drugs Market Share by Application: 2024 VS 2031

Figure 11. Hospitals Case Studies

Figure 12. Clinics Case Studies

Figure 13. Others Case Studies

Figure 14. Irritable Bowel Syndrome with Constipation Drugs Report Years Considered

Figure 15. Global Irritable Bowel Syndrome with Constipation Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Irritable Bowel Syndrome with Constipation Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Irritable Bowel Syndrome with Constipation Drugs Market Share by Region: 2024 VS 2031

Figure 18. Global Irritable Bowel Syndrome with Constipation Drugs Market Share by Players in 2024

Figure 19. Global Top Irritable Bowel Syndrome with Constipation Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome with Constipation Drugs as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome with Constipation Drugs Revenue in 2024

Figure 21. North America Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Irritable Bowel Syndrome with Constipation Drugs Market Share by Country (2020-2031)

Figure 23. United States Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Irritable Bowel Syndrome with Constipation Drugs Market Share by Country (2020-2031)

Figure 27. Germany Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Irritable Bowel Syndrome with Constipation Drugs Market Share by Region (2020-2031)

Figure 35. China Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Irritable Bowel Syndrome with Constipation Drugs Market Share by Country (2020-2031)

Figure 43. Mexico Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Irritable Bowel Syndrome with Constipation Drugs Market Share by Country (2020-2031)

Figure 47. Turkey Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Irritable Bowel Syndrome with Constipation Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Nestle Revenue Growth Rate in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

Figure 51. Abbot Laboratories Revenue Growth Rate in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

Figure 52. Synergy Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

Figure 53. Sucampo Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

Figure 54. Novartis Revenue Growth Rate in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

Figure 55. Astellas Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

Figure 56. Mallinckrodt Revenue Growth Rate in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

Figure 57. Bausch Health Companies Revenue Growth Rate in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

Figure 58. Ardelyx Revenue Growth Rate in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

Figure 59. Ironwood Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

Figure 60. Takeda Pharmaceutical Revenue Growth Rate in Irritable Bowel Syndrome with Constipation Drugs Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Irritable Bowel Syndrome with Diarrhea IBS D Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Irritable Bowel Syndrome IBS Market Insights Forecast to 2030

Irritable Bowel Syndrome IBS Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rx Irritable Bowel Syndrome IBS Drugs Market Insights Forecast to 2030

Irritable Bowel Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global IBS C Drugs Market Research Report 2024

Global Gastrointestinal Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Functional Dyspepsia Drug Market Insights Forecast to 2030

Global Gastrointestinal Therapeutics Market Research Report 2024

Global Irritable Bowel Syndrome Drug Market Research Report 2024

Global Gastrointestinal Drugs Market Research Report 2025

Global Amebiasis Drugs Market Insights Forecast to 2030

Global IBS Probiotic Supplement Market Research Report 2024

Global Digestive Drugs Market Insights Forecast to 2030

Chronic Idiopathic Constipation Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti spasmodic Drugs Market Insights Forecast to 2030

Global Opioid Induced Constipation OIC Drugs Market Research Report 2024

Global Irritable Bowel Syndrome Medication Market Research Report 2025

Global Opioid Induced Constipation Drugs Market Research Report 2024

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19Z7671

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10V14317

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10O5919

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4I19963

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions